Replication capacity of minority variants in viral populations can affect the assessment of resistance in HCV chimeric replicon phenotyping assays

T. Verbinnen, T. Jacobs, L. Vijgen, H. Ceulemans, J. Neyts, G. Fanning, O. Lenz
  • Journal of Antimicrobial Chemotherapy, June 2012, Oxford University Press (OUP)
  • DOI: 10.1093/jac/dks234
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Thierry Verbinnen